Valuation : Kuros Biosciences AG

Market Cap 723M 886M 763M 655M 1.23B 84.65B 1.24B 8.59B 3.3B 43.07B 3.33B 3.25B 136B P/E 2026 *
88.3x
P/E 2027 * 37.9x
Enterprise Value 712M 873M 752M 645M 1.21B 83.4B 1.22B 8.46B 3.25B 42.43B 3.28B 3.21B 134B EV / Sales 2026 *
4.27x
EV / Sales 2027 * 3.05x
Free-Float
68.55%
Yield 2026 *
-
Yield 2027 * -
1 day-2.25%
1 week+2.76%
Current month-7.04%
1 month-20.78%
3 months-11.12%
6 months-29.76%
Current year-33.70%
1 week 17.2
Extreme 17.2
19.48
1 month 17.2
Extreme 17.2
23.9
Current year 17.2
Extreme 17.2
30.3
1 year 17.2
Extreme 17.2
34.2
3 years 2
Extreme 2
34.2
5 years 1.11
Extreme 1.11
34.2
10 years 1.11
Extreme 1.11
34.2
Manager TitleAgeSince
Chief Executive Officer 56 2023-10-11
Chief Executive Officer 60 2017-12-03
Director of Finance/CFO - 2023-02-16
Director TitleAgeSince
Chairman 69 2018-06-13
Director/Board Member 60 2018-06-13
Director/Board Member 57 2018-06-13
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/26 Sell -7,225 0.0184%
12/13/25 Sell 30,000 0.0766%
12/8/25 Sell 30,000 0.0766%
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%+2.76%-22.47%+767.62% 886M
-2.11%-1.68%+43.40%+95.27% 66.93B
-0.23%-4.45%+32.50%+75.75% 61.97B
+1.67%+2.47%-11.32%+380.54% 28.26B
-1.05%-4.43%+28.84%+10.59% 24.59B
+0.34%-6.78%-0.01%-16.35% 24.3B
+0.43%-3.37%+16.22%-17.99% 19.41B
-3.03%-2.29%+181.72%+335.27% 16.77B
-1.94%-4.94%-8.15%+483.69% 14.18B
+3.24%-0.31%-7.34%+880.45% 14B
Average -0.49%-2.38%+25.34%+299.48% 27.13B
Weighted average by Cap. -0.56%-2.81%+31.08%+172.60%

Financials

2026 *2027 *
Net sales 167M 204M 176M 151M 283M 19.51B 285M 1.98B 761M 9.93B 767M 750M 31.37B 224M 274M 236M 203M 380M 26.18B 382M 2.66B 1.02B 13.32B 1.03B 1.01B 42.09B
Net income 9.32M 11.43M 9.84M 8.45M 15.85M 1.09B 15.93M 111M 42.57M 555M 42.91M 41.97M 1.75B 21.65M 26.54M 22.87M 19.62M 36.82M 2.54B 37M 257M 98.88M 1.29B 99.67M 97.48M 4.08B
Net Debt -10.7M -13.11M -11.3M -9.69M -18.19M -1.25B -18.28M -127M -48.85M -637M -49.24M -48.16M -2.01B -41.26M -50.57M -43.57M -37.39M -70.15M -4.83B -70.51M -490M -188M -2.46B -190M -186M -7.77B
Logo Kuros Biosciences AG
Kuros Biosciences AG is a Switzerland‑based biotechnology company engaged in the research, development, and commercialization of biologic technologies for musculoskeletal care, with a focus on those supporting bone regeneration and bone growth. The Company's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. It is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Employees
178
Date Price Change Volume
26-09-11 CHF 18.22 -2.25% 185,114
26-09-10 CHF 18.64 -0.96% 170,708
26-09-09 CHF 18.82 -2.34% 139,009
26-09-08 CHF 19.27 +3.66% 220,272
26-09-07 CHF 18.59 +4.85% 440,128
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18.22CHF
Average target price
33.92CHF
Spread / Average Target
+86.14%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KURN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!